The 2023-2028 World Outlook for Immunoglobulin a (IgA)
In this report we define the sales of immunoglobulin a (IgA) as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Bharat Serums and Vaccines, Biotest, China Biologic Products, CSL, Grifols,, GuiZhou TaiBang Biological Products Company, Hualan Biological Engineering, Kedrion, LFB Group, Octapharma, Shanghai RAAS Blood Products Company, Shire, and Sichuan Yuanda Shuyang Pharmaceutical Company. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication’s release in 2022).
Reviews
There are no reviews yet.